Newark, Delaware

Reproductive Associates of Delaware

Infertility

Amenorrhea

Aneuploidy

Endometriosis

Pelvic Pain

Hypogonadism

Female Infertility

NT100

Progesterone

Gonadorelin acetate

Ferring

Aspira Women's Health

Femasys

Fertility Biotech

IBSA

Illumina

Nora Therapeutics

condition

allSponsorName

gender

Male

Female

overallStatus

Recruiting

Not yet recruiting

Active, not recruiting

Enrolling by invitation

Completed

Terminated

Withdrawn

Suspended

Unknown

type

Interventional

Observational

Expanded Access

phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Not Applicable

funderTypes

Industry

Other U.S. Federal agency

All others

ageGroup

Child (birth-17)

Adult (18-64)

Older Adult (65+)

This is a multicenter, randomized, double-blind, double-dummy, active-controlled, non-inferiority clinical study in women aged 35 to 42 years. This study will investigate the safety and efficacy of Progesterone-IBSA to support euploid embryo blastocyst implantation and early pregnancy after frozen embryo transfer (FET) in a modified natural cycle as a treatment for infertile women. Subjects will be randomized to receive either active Progesterone-IBSA or Crinone 8% for luteal and early pregnancy support and these two groups will be compared.

Subcutaneous Progesterone in Frozen- Thawed Single Euploid Blastocyst Transfer.

Reproductive Associates of Delaware | Newark, Delaware

Site insights

Work at this site?

Active trials

Subcutaneous Progesterone in Frozen- Thawed Single Euploid Blastocyst Transfer. (PROGRESS)

Trial sponsors